$2.63 -0.08 (-2.95%)
11/27/2009 1:00 PM

SuperGen, Inc. (SUPG)

CAPS Rating: 5 out of 5

A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.

Featured Broker Partners